Vít Procházka - Concepedia

Author

Vít Procházka

Also Known As

Prochazka V, Prochazka, V, Prochazka, Vit, Procházka, Vít, V Prochazka, V Procházka, V. PROCHAZKA, V. Prochazka, V. Procházka, VIT K Prochazka

178

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Palacký University Olomouc University Hospital Olomouc Charles University University Hospital Brno Masaryk University

About

Vít Procházka is an author at Palacký University Olomouc specializing in pathology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	242
2	Health Sciences	3	3	100
3	Engineering	1	1	56
4	Cell Biology	1	1	44
5	Cellular Therapies	1	1	33

Vít Procházka

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Older Patients with Mantle-Cell Lymphoma Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, New England Journal of Medicine	2012	511
miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels Kateřina Musilová, Ján Deván, Kateřina Amruz Černá, Blood	2018	72
2-[18F]fluoro-2-deoxy-<scp>d</scp>-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation Tomáš Papajík, M Mysliveček, Renata Urbanová, Leukemia & lymphoma/Leukemia and lymphoma EngineeringChronic Lymphocytic LeukemiaPet-mriPathologyPositron Emission Tomography	2013	56
Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects Gayane Manukyan, Tomáš Papajík, Petr Gajdoš, Oncotarget InflammationHematological MalignancyChronic Lymphocytic LeukemiaGranulocyteImmune Cell Development	2017	44
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent Vít Procházka, Robert Pytlík, Andrea Janíková, PLoS ONE	2014	40
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients Andrea Janíková, Renata Chloupková, Vít Campr, Annals of Hematology Hematological MalignancyLymphoid NeoplasiaFirst-line TherapyCell TherapyT Cell Lymphomas	2019	33
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy? Andrea Janíková, Zbyněk Bortlíček, Vít Campr, Leukemia & lymphoma/Leukemia and lymphoma	2014	32
TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma Aleš Obr, Vít Procházka, Andrea Jirkuvová, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyLymphoid NeoplasiaTp53 MutationHealth SciencesMantle Cell Lymphoma	2018	32
Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry Heidi Móciková, Robert Pytlík, Alice Šýkorová, Leukemia & lymphoma/Leukemia and lymphoma Neuro-oncologyLymphoid NeoplasiaMedicineCancer ManagementMetronomic Therapy	2016	30
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin’s lymphoma Tomáš Papajík, M Mysliveček, Z. Šedová, European Journal Of Haematology	2010	29

Page 1